BECTON DICKINSON & CO (BDX) Options Risk Score
Real-time risk analysis for BDX options traders — updated every 30 minutes.
Data last updated: 2026-07-23
Run a full BDX options risk analysis
See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.
Scan BDX Now — Free →
Is it risky to sell options on BECTON DICKINSON & CO (BDX) right now?
BECTON DICKINSON & CO (BDX) currently scores 100 out of 100 for options catalyst risk (HIGH) over a 4-week expiry window. What pushes it there: 7 recent news items, 3 active legal filings, 1 recent SEC event and 16 clinical-trial catalysts, all landing inside the 4-week window. On TickerRisk's scale 70 and above is HIGH, so a known event is scheduled inside this window — selling premium on BDX here is a bet on that event rather than on time decay. The score measures scheduled event exposure, not which way the stock will move.
BDX shows an IV Rank of 100 — implied volatility is near the top of its own one-year range, so BDX options are historically expensive, which favours premium-selling strategies, with a current implied volatility of about 118%. IV Rank is the most useful figure for deciding whether to sell or buy premium on BDX.
The next BDX report is not until 2026-08-06, beyond the near-term window.
TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer